DE60140526D1 - Herstellung von tcr gamma delta t-zellen - Google Patents

Herstellung von tcr gamma delta t-zellen

Info

Publication number
DE60140526D1
DE60140526D1 DE60140526T DE60140526T DE60140526D1 DE 60140526 D1 DE60140526 D1 DE 60140526D1 DE 60140526 T DE60140526 T DE 60140526T DE 60140526 T DE60140526 T DE 60140526T DE 60140526 D1 DE60140526 D1 DE 60140526D1
Authority
DE
Germany
Prior art keywords
cells
gamma delta
tcr gamma
preparation
growth factors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60140526T
Other languages
English (en)
Inventor
David N Bell
Danna L Skea
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Therapure Biopharma Inc
Original Assignee
Therapure Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therapure Biopharma Inc filed Critical Therapure Biopharma Inc
Application granted granted Critical
Publication of DE60140526D1 publication Critical patent/DE60140526D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/515—CD3, T-cell receptor complex
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DE60140526T 2000-04-03 2001-04-03 Herstellung von tcr gamma delta t-zellen Expired - Lifetime DE60140526D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19403300P 2000-04-03 2000-04-03
PCT/CA2001/000444 WO2001075072A2 (en) 2000-04-03 2001-04-03 PRODUCTION OF TcR GAMMA DELTA T CELLS

Publications (1)

Publication Number Publication Date
DE60140526D1 true DE60140526D1 (de) 2009-12-31

Family

ID=22716029

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60140526T Expired - Lifetime DE60140526D1 (de) 2000-04-03 2001-04-03 Herstellung von tcr gamma delta t-zellen

Country Status (9)

Country Link
EP (1) EP1268746B1 (de)
JP (1) JP4982645B2 (de)
AT (1) ATE449162T1 (de)
AU (2) AU2001248162B2 (de)
CA (1) CA2405050C (de)
DE (1) DE60140526D1 (de)
ES (1) ES2336302T3 (de)
NZ (1) NZ522337A (de)
WO (1) WO2001075072A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1948788A4 (de) 2005-11-18 2009-07-01 Univ Health Network Verfahren zur expansion doppelt negativer t-zellen
WO2008016078A1 (fr) 2006-08-01 2008-02-07 Arigen Pharmaceuticals, Inc. Procédé de prolifération d'une cellule lak
BR112017000464A2 (pt) * 2014-07-09 2017-11-07 Tc Biopharm Ltd células gama delta t e uso das mesmas
GB201506423D0 (en) 2015-04-15 2015-05-27 Tc Biopharm Ltd Gamma delta T cells and uses thereof
EA201890013A1 (ru) 2015-06-09 2018-07-31 Лимфакт - Лимфоцит Активэйшн Текнолоджис, С.А. Способы получения tcr гамма дельтат-клеток
JP6621171B2 (ja) * 2015-06-22 2019-12-18 国立大学法人広島大学 Ｔ細胞活性化剤、ｔ細胞の活性化方法、および、ｔ細胞培養用培地
SG11202100260QA (en) 2018-07-13 2021-02-25 Univ Kyoto METHOD FOR PRODUCING γδ T CELLS
AR120538A1 (es) 2019-11-25 2022-02-23 Univ Kyoto Banco de células maestras de células t

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2278847A1 (en) * 1997-01-31 1998-08-06 Hemosol Inc. Method for the production of selected lymphocytes
JPH10295368A (ja) * 1997-04-22 1998-11-10 Hitachi Chem Co Ltd ガンマー・デルタｔ細胞の製造法及び免疫治療剤
AU746531B2 (en) * 1998-03-12 2002-05-02 Emory University Methods and compositions for the selective expansion of gamma/delta T-cells
EP1127107B1 (de) * 1998-11-04 2009-01-21 Therapure Biopharma Inc. Verfahren zur herstellung von gamma delta t zellen

Also Published As

Publication number Publication date
NZ522337A (en) 2004-12-24
JP4982645B2 (ja) 2012-07-25
CA2405050C (en) 2010-06-15
WO2001075072A2 (en) 2001-10-11
CA2405050A1 (en) 2001-10-11
WO2001075072A3 (en) 2002-04-25
EP1268746A2 (de) 2003-01-02
AU2001248162B2 (en) 2007-02-01
AU4816201A (en) 2001-10-15
ATE449162T1 (de) 2009-12-15
EP1268746B1 (de) 2009-11-18
JP2003529363A (ja) 2003-10-07
ES2336302T3 (es) 2010-04-12

Similar Documents

Publication Publication Date Title
HUP0105052A2 (hu) Eljárások nukleinsav amplifikálására és szekvenálására
DE60323468D1 (de) Vögelzell-linien und deren verwendung zur herstellung interessanter biologischer substanzen
CA2058930A1 (en) Media for cell growth and method for making them
ATA165999A (de) Medium zur protein- und serumfreien kultivierung von zellen
BR0311413A (pt) Desenvolvimento e transdiferenciação de células acinares humanas
FR2543158B1 (fr) Milieu de culture de cellules animales sans serum, sans hormones et sans facteurs de croissance et procedes de culture primaire et d'obtention de lignees cellulaires utilisant ce milieu
EA199800835A1 (ru) Среда для культуры клеток млекопитающихся, способ ее получения и смесь компонентов, композиция, способы получения, продуцирования клонального роста, размножения и изменения фенотипа гепатоцитов in vitro, клетки, фармацевтический состав, способы получения рекомбинантной клетки и генного продукта, способы использования клеток, способ трансплантации гепатоцитов, способ испытания лекарственного препарата, способ поддержания жизнеспособности дифференцированных гепатоцитов
DE69939947D1 (de) Verfahren zur herstellung von polypeptiden in mutierten aspergillus zellen
ATE399855T1 (de) Tierzellkulturmedium mit pflanzlichen nährstoffen
ES2120946T3 (es) Sistemas y medios de cultivo celular.
EP1736536A3 (de) Zellkulturspinnerflaschen
DE69735059D1 (de) Erhöhte produktion von taxanen durch zellkulturen von taxus-arten
DE60140526D1 (de) Herstellung von tcr gamma delta t-zellen
PT1200561E (pt) Clone celular recombinante estavel, sua producao e utilizacao
ATE421573T1 (de) Verfahren zur herstellung von gamma delta t zellen
ATE15693T1 (de) Zellkultur-verfahren.
ATE469209T1 (de) Herstellung und verwendung von basalmembranpartikeln
EP2281892A3 (de) Verfahren zur Herstellung von Polypeptiden in atmungsdefizienten Trichoderma Zellen
DK0651788T3 (da) Fremgangsmåde til dyrkning af en celletype i en cokulturfremgangsmåde med leverceller
RU2009149159A (ru) Способы предотвращения глюконилирования белков
DE69014723T2 (de) Zellzüchtungsverfahren.
DE69923595D1 (de) Herstellung von proteinen
JPS5558092A (en) Method of culturing tubercle bacillus
JPS5519066A (en) Preparation of keratinase
KR910012253A (ko) 폴리-3-히드록시부티르산의 생합성 방법

Legal Events

Date Code Title Description
8364 No opposition during term of opposition